| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals, Inc. (REGN) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 76 sells. REGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 310.5K | $189.36M | - | |
| CEO | 214.5K | $130.85M | - | |
| VP | 47.8K | $29.18M | - | |
| VP | 29.5K | $18.00M | - | |
| VP | 21.7K | $13.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2024 | Fenimore Christopher R.66 | SVP Finance &CFO | Sell | 5,680 | $1,205.33 | $6,846,262.22 | -61.9% | -37.2% | -51.7% | |
| Aug 15, 2024 | Bassler Bonnie L59 | Director | Sale+OE | 756 | $1,170.00 | $884,520.00 | -35.4% | -31.6% | -50.6% | |
| Aug 15, 2024 | Poon Christine A51 | Director | Sale+OE | 10,838 | $1,158.17 | $12,552,284.50 | -19.6% | -31.6% | -50.6% | |
| Aug 14, 2024 | Murphy Andrew J54 | EVP Research | Sale+OE | 6,363 | $1,153.15 | $7,337,504.87 | -0.7% | -29.0% | -51.1% | |
| Aug 8, 2024 | Stahl Neil | EVP Research And Development | Sell | 5,197 | $1,084.54 | $5,636,346.27 | -1.6% | -26.6% | -49.4% | |
| Aug 7, 2024 | Pitofsky Jason | VP Controller | Sale+OE | 487 | $1,070.00 | $521,090.00 | -10.4% | -22.3% | -47.6% | |
| Aug 2, 2024 | Bassler Bonnie L59 | Director | Sale+OE | 756 | $1,115.00 | $842,940.00 | -35.4% | -22.5% | -48.4% | |
| Aug 1, 2024 | McCourt Marion55 | EVP Commercial | Sale+OE | 1,137 | $1,060.86 | $1,206,197.82 | -8.1% | -15.6% | -48.9% | |
| Aug 1, 2024 | Ryan Arthur F54 | Director | Sell | 99 | $1,085.53 | $107,467.07 | - | -15.6% | -48.9% | |
| Aug 1, 2024 | Ryan Arthur F54 | Director | Sell | 1 | $1,100.03 | $1,100.03 | - | -15.6% | -48.9% |